Literature DB >> 14762630

Immunoprecipitation techniques and Elisa in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis.

Mónica Scarpelli Martinelli Vidal1, Luis Guilherme Martins de Castro, Sônia Cristina Cavalecate, Carlos da Silva Lacaz.   

Abstract

Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by several dematiaceous fungi. The most commonly etiological agent found in Brazil is Fonsecaea pedrosoi, which appears as thick walled, brownish colored cells with transverse and longitudinal division in the lesions, called "muriform cells". This disease is found worldwide but countries like Madagascar and Brazil have highest incidence. Diagnosis is made by clinical, direct and histopathologic examination and culture of specimens. Serological tests have been used to identify specific antibodies against Fonsecaea pedrosoi antigens, as well as immunotechniques have been used for CBM serological identification and diagnosis. In the present study double immunodiffusion (DID), counterimmunoelectrophoresis (CIE) and immunoenzymatic test (ELISA) have been used to evaluate humoral immune response in patients with CBM caused by F. pedrosoi. Metabolic antigen was used for immunoprecipitation tests (DID and CIE) while somatic antigen for ELISA. Our results demonstrated 53% sensitivity and 96% specificity for DID, while CIE presented 68% sensitivity and 90.5% specificity. ELISA demonstrated 78% sensibility and 83% specificity. Serological tests can be a useful tool to study different aspects of CBM, such as helping differential diagnosis, when culture of the pathogenic agent is impossible.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762630     DOI: 10.1590/s0036-46652003000600003

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  5 in total

1.  Use of mycelial-phase Sporothrix schenckii exoantigens in an enzyme-linked immunosorbent assay for diagnosis of sporotrichosis by antibody detection.

Authors:  Rodrigo Almeida-Paes; Monique A Pimenta; Claudia Vera Pizzini; Paulo Cezar F Monteiro; José Mauro Peralta; Joshua D Nosanchuk; Rosely Maria Zancopé-Oliveira
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

2.  Delayed-type hypersensitivity response to crude and fractionated antigens from Fonsecaea pedrosoi CMMI 1 grown in different culture media.

Authors:  Valeriano Antonio Corbellini; Maria Lúcia Scroferneker; Mariana Carissimi; Luciane Domingues Santolin
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

Review 3.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Accuracy of direct examination and culture as compared to the anatomopathological examination for the diagnosis of chromoblastomycosis: a systematic review.

Authors:  Jules Rimet Borges; Bárbara Álvares Salum Ximenes; Flávia Tandaya Grandi Miranda; Giordana Bruna Moreira Peres; Isabella Toscano Hayasaki; Luiz César de Camargo Ferro; Mayra Ianhez; Marco Tulio Antonio Garcia-Zapata
Journal:  An Bras Dermatol       Date:  2022-05-25       Impact factor: 2.113

5.  Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.

Authors:  C D M P e Silva de Azevedo; O Bruña-Romero; S G Marques; F R F do Nascimento; M C Pinto; L A Silva; L E M Bouillet; F S de Azevedo; M A de Resende Stoianoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-15       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.